Brenus Pharma
Clinical-stage immunotherapy company developing novel treatments for cancer.
About
Brenus Pharma is a biotechnology company focused on developing innovative in-vivo immunotherapies for cancer treatment. Their lead candidate, STC-1010, is in clinical development for MSS mCRC. The company leverages a proprietary platform for multi-asset expansion. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Brenus Pharma do?
Brenus Pharma is a Biotechnology company that offers Platform. Teams look it up for Pharmaceuticals, Healthcare, Biotech. It is based in Lyon, France. Public records show about 29 people and $13M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Brenus Pharma raised?
Brenus Pharma has raised a total of $13M in funding. The most recent round on record is Series A.
Where is Brenus Pharma headquartered?
Brenus Pharma is headquartered in Lyon, France.
What industry does Brenus Pharma operate in?
Brenus Pharma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery.
How many employees does Brenus Pharma have?
Brenus Pharma has approximately 29 people on record.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.